Home > Insider Trading > Filing (0001140361-15-045654)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367644	Emergent Biosolutions Inc.	EBS	Pharmaceutical Preparations (2834)	141902018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380187	Daniel Abdun-Nabi	400 Professional Dr, Suite 400 Gaithersburg MD 20879	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-12-23	40,354	$18.90	225,722	No	4	M	Direct
Common Stock	Disposition	2015-12-23	40,354	$38.99	185,368	No	4	S	Direct
Common Stock	Acquisiton	2015-12-24	22,855	$18.90	208,223	No	4	M	Direct
Common Stock	Disposition	2015-12-24	22,855	$39.17	185,368	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2015-12-23	40,354	$0.00	40,354	$18.90
Common Stock	Stock Option	Disposition	2015-12-24	22,855	$0.00	22,855	$18.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,855		2019-03-09	No	4	M	Direct
0		2019-03-09	No	4	M	Direct

Footnotes

Consists of an option granted under the company's stock incentive plan on March 10, 2009.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.79 to $39.11, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.99 to $39.48, inclusive.
The option vested in three equal installments in March 2010, 2011 and 2012.